liposomal oxaliplatin January 19, 2018 liposomal oxaliplatin Trade Name Orphan Indication Pancreatic adenocarcinoma USA Market Approval USA USA Designation Date 2017-09-18 00:00:00 Sponsor KC Specialty Therapeutics, LLC;2002 West 39th Avenue;Kansas City, Arkansas, 66103
